Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer | BMC Cancer | Full Text

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer | BMC Cancer | Full Text

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer

Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who m...

Authors:Kyung Jin Eoh, Hye Min Kim, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Young Tae Kim and Eun Ji Nam

Citation:BMC Cancer 2020 20:204

Content type:Research article

Published on: 12 March 2020

• ViewFull Text
 
• ViewPDF